Camphor toxicity: Difference between revisions

(clinical features)
(treatment)
Line 10: Line 10:
*Seizure, respiratory depression, coma
*Seizure, respiratory depression, coma
*Hepatitis and liver failure
*Hepatitis and liver failure
==Treatment==
*Aggressive supportive care<ref>American Academy of Pediatrics Policy Statement. Camphor Revisited: Focus on Toxicity (RE9422). Pediatrics 1994;94:127-128</ref>
*Benzodiazepines for seizure
*Intubation and mechanical ventilation as needed
*Charcoal not likely effective


==References==
==References==

Revision as of 02:12, 22 January 2016

Background

  • Common topical agent for pain relief, wart removal, osteoarthritis, cold sores
  • FDA limits over the counter preparations to 11%[1]
  • Highly lipophilic, widely and rapidly distributed, symptom onset 5-15 minutes

Clinical Features

  • Nausea, vomiting, abdominal pain
  • Oral burning, headache
  • Vertigo, confusion, agitation
  • Seizure, respiratory depression, coma
  • Hepatitis and liver failure

Treatment

  • Aggressive supportive care[2]
  • Benzodiazepines for seizure
  • Intubation and mechanical ventilation as needed
  • Charcoal not likely effective

References

  1. United States Food and Drug Administration. Proposed rules: external analgesic drug products for over-the-counter human use; tentative final monograph. Fed Reg 1983
  2. American Academy of Pediatrics Policy Statement. Camphor Revisited: Focus on Toxicity (RE9422). Pediatrics 1994;94:127-128